Quintal scabies - Symptoms, Causes, Treatment & Prevention

```html Quintal Scabies – Complete Medical Guide

Quintal Scabies – A Comprehensive Medical Guide

Overview

Quintal scabies (also called “crusted scabies” or “Norwegian scabies”) is a severe, highly contagious form of scabies caused by an over‑growth of the mite Sarcoptes scabiei on the skin. Unlike classic scabies, which typically produces a few itchy bumps, quintal scabies results in thick, crusted lesions that can cover large body surfaces—sometimes up to a full “quintal” (100 kg) of skin, hence the name.

The condition most often affects people whose immune systems are compromised or who have limited ability to maintain personal hygiene. Worldwide, scabies affects an estimated 200 million people each year, and crusted scabies accounts for 2–10 % of those cases, making it a relatively rare but serious public‑health concern.[1] WHO, 2022

Typical demographic groups include:

  • Elderly residents of long‑term care facilities.
  • Individuals with HIV/AIDS, lymphoma, or other immunosuppressive conditions.
  • Patients on long‑term corticosteroids, chemotherapy, or biologic agents.
  • People with neurological disorders that impair scratching (e.g., dementia, spinal cord injury).

Symptoms

Quintal scabies presents with a distinct set of clinical features that differ from ordinary scabies. The following list is comprehensive; not every patient will experience all items.

Skin Manifestations

  • Thick, hyperkeratotic crusts – often gray‑white or yellow‑brown, covering large areas such as the hands, feet, elbows, knees, scalp, and sometimes the entire body.
  • Psoriasiform plaques – raised, scaly patches that can mimic psoriasis.
  • Vesicles or pustules – small fluid‑filled lesions that may become secondarily infected.
  • Excoriations – linear or irregular scratches; however, many patients have limited scratching because of neuropathy.
  • Fissures and crusted ulcers – deep cracks in the skin, especially on the palms and soles.

Systemic and General Symptoms

  • Intense itching – may be less pronounced than classic scabies because of reduced sensation, but when present it is often nocturnal.
  • Fever, chills, malaise – usually signal secondary bacterial infection.
  • Weight loss or fatigue – associated with chronic infection and inflammation.

Complicating Signs

  • Secondary bacterial infection (e.g., Staphylococcus aureus or Streptococcus pyogenes) leading to cellulitis, impetigo, or even sepsis.
  • Increased itchiness after treatment (a “post‑treatment flare”) caused by die‑off of mites.

Causes and Risk Factors

Quintal scabies is caused by the same microscopic mite (Sarcoptes scabiei var. hominis) that produces classic scabies. The key difference lies in the host’s inability to control mite proliferation.

Pathophysiology

  1. The female mite burrows into the stratum corneum to lay eggs.
  2. In healthy individuals, an immune response limits the mite population to ~10–15 per square centimeter.
  3. In immunocompromised or neurologically impaired hosts, the mite count can exceed 1,000 per cmÂČ, leading to the massive crusted lesions.

Major Risk Factors

  • Immunosuppression – HIV/AIDS (especially CD4 < 200 cells/”L), organ transplant recipients, chemotherapy.
  • Neurologic impairment – dementia, Parkinson’s disease, spinal cord injury, peripheral neuropathy.
  • Skin barrier disruption – chronic dermatitis, eczema, poor hygiene, crowded living conditions.
  • Advanced age – reduced cellular immunity and limited ability to scratch.
  • Institutional setting – nursing homes, psychiatric facilities, prisons where close contact is common.

Diagnosis

A timely and accurate diagnosis is critical because quintal scabies is highly contagious.

Clinical Evaluation

  • History of intense itching, recent institutional stay, or known immunosuppression.
  • Physical exam revealing thick crusted plaques, often on the hands, feet, and scalp.

Dermatologic Tests

  1. Skin scraping – the most definitive test. A scalpel blade or a dermal curette is used to collect material from the crusted area; the sample is examined under a microscope for mites, eggs, or feces.
  2. Skin surface biopsy (adhesive tape test) – a piece of clear tape is pressed to the lesion, lifted, and examined microscopically. It is especially useful when crusts are hard to scrape.
  3. Dermoscopy – handheld dermatoscopes can show the characteristic “delta wing” or “jet with contrail” pattern of the mite burrow.

Laboratory Work‑up (if secondary infection is suspected)

  • Complete blood count (CBC) – may show leukocytosis.
  • Blood cultures – indicated if fever or systemic signs of infection are present.
  • Wound swab culture – to direct antibiotic therapy for bacterial superinfection.

When to Involve Specialists

Dermatologists, infectious disease physicians, or geriatric specialists should be consulted for complex cases, especially when the patient requires isolation or when treatment resistance is suspected.

Treatment Options

Effective management requires a combined approach: topical agents, systemic medication, environmental decontamination, and close monitoring.

First‑Line Pharmacologic Therapy

  1. Ivermectin (oral) – 200 ”g/kg PO once daily for 2–7 days. In severe crusted cases, a dosing schedule of days 1, 2, 8, 9, and 15 is recommended.[2] CDC, 2023 Repeat courses may be needed until skin clears.
  2. Topical scabicides – 5 % permethrin cream applied overnight to the entire body (including scalp) for 8–14 hours, then washed off. In crusted disease, the cream should be applied under occlusion (plastic wrap) to improve penetration.

Adjunctive Therapies

  • Keratinolytic agents – 10 % salicylic acid or 12 % urea creams applied before scraping to soften crusts and enhance topical drug absorption.
  • Antibiotics – oral doxycycline, clindamycin, or vancomycin if secondary bacterial infection is documented.
  • Antihistamines – diphenhydramine or cetirizine for pruritus control.

Supportive Care & Lifestyle Measures

  • Gentle debridement of crusts by a trained nurse or dermatologist to allow medication to reach mites.
  • Cool compresses or oatmeal baths to soothe irritated skin.
  • Maintain adequate hydration and nutrition to support skin healing.

Considerations for Special Populations

  • Pregnant or lactating women – topical permethrin is preferred; oral ivermectin is generally avoided unless benefits outweigh risks.
  • Young children (<2 years) – 5 % permethrin is safe; dosing of ivermectin is weight‑adjusted and used only under specialist supervision.
  • Renal or hepatic impairment – monitor ivermectin levels; dose reduction may be necessary.

Living with Quintal Scabies

Even after the infection is cleared, patients often need ongoing skin care and monitoring.

Daily Skin Care Routine

  1. Wash the entire body daily with a mild, fragrance‑free cleanser.
  2. After bathing, apply a moisturizer containing ceramides or colloidal oatmeal to keep the stratum corneum supple.
  3. Inspect the skin weekly for new crusts or signs of infection.

Clothing & Bedding

  • Change underwear and socks daily; wash all garments in hot water (≄ 60 °C) and dry on high heat.
  • Use washable pillowcases and sheets; replace after each treatment cycle.
  • Consider disposable underwear for the first week of treatment if skin is heavily crusted.

Social & Psychological Support

  • Inform household members and caregivers about the contagious nature and necessary precautions.
  • Connect with support groups for chronic skin conditions; stigma can affect mental health.
  • Work with a social worker if you reside in a long‑term care facility to ensure proper isolation protocols.

Prevention

Because crusted scabies spreads rapidly, prevention is a public‑health priority.

  1. Early detection – Prompt evaluation of any unexplained itch or skin changes, especially in high‑risk settings.
  2. Isolation of cases – Treat patients in a separate room; use personal protective equipment (gloves, gowns) for staff.
  3. Environmental cleaning – Wash all fabrics in hot water, vacuum upholstery, and apply a 1 % bleach solution to hard surfaces.
  4. Regular skin examinations – For residents of nursing homes or patients on immunosuppressants, schedule quarterly skin checks.
  5. Education – Provide caregivers with hand‑hygiene training and information on how scabies spreads.

Complications

If left untreated, quintal scabies can lead to serious health problems.

  • Secondary bacterial infection – cellulitis, impetigo, or necrotizing fasciitis; may progress to sepsis.
  • Scarring and disfigurement – chronic crusts can cause permanent skin thickening.
  • Systemic inflammation – prolonged immune activation can exacerbate underlying chronic diseases.
  • Outbreaks in institutions – one untreated case can infect dozens of residents or staff.
  • Psychological impact – chronic itching and visible lesions often lead to anxiety, depression, and social isolation.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you notice any of the following:
  • Fever > 101 °F (38.3 °C) together with rapidly spreading redness or swelling (possible cellulitis).
  • Severe pain, throbbing or a “burning” sensation that does not improve with pain meds.
  • Signs of systemic infection: rapid heart rate, low blood pressure, confusion, or difficulty breathing.
  • Extensive skin breakdown with pus, foul odor, or blackened tissue (possible necrotizing infection).
  • Sudden onset of dizziness, fainting, or a rash that spreads beyond the known scabies lesions.
Prompt emergency treatment can prevent life‑threatening complications.

References

  1. World Health Organization. Scabies: Global Burden and Control Strategies. WHO Press, 2022.
  2. Centers for Disease Control and Prevention. “Guidelines for the Treatment of Scabies.” Updated 2023. https://www.cdc.gov/parasites/scabies/treatment.html
  3. Mayo Clinic. “Scabies - Symptoms and causes.” 2024. https://www.mayoclinic.org/diseases-conditions/scabies/symptoms-causes/syc-20377381
  4. Cleveland Clinic. “Crusted (Norwegian) Scabies.” 2023. https://my.clevelandclinic.org/health/diseases/23644-crusted-scabies
  5. National Institutes of Health. “Ivermectin for Scabies: Clinical Use and Safety.” 2022. PubMed Central
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.